Baraclude for Chronic Hepatitis B Treatment: Key Concerns and Insights

The treatment for hepatitis B is Baraclude?

Dear Doctor,
I hope this message finds you well.
I previously asked you several questions regarding the treatment of hepatitis B, and I now have a few more concerns that I would like to outline below:
1.
I have been taking Baraclude (entecavir) 0.5 mg for nearly six months.
My liver enzymes have decreased, but the viral load has not been tested yet.
If Baraclude only suppresses the replication of hepatitis B DNA in the bloodstream, how is it that the virus previously present in the blood is not eliminated? Does this mean that the virus continues to replicate within the liver cells, causing ongoing inflammation and leading to fibrosis?
2.
If I optimistically reach a point where I can stop medication after three consecutive tests showing no detectable DNA in the blood, what is the likelihood of relapse in the future? Would I need to resume medication, or are there no available treatments to suppress any potential mutations? I am an e-antigen negative hepatitis B patient and know that I have a mutant strain, but I am unclear about the specific type.
Could this mutation be due to my immune system's inability to control it, allowing for continued replication? Many individuals are inactive carriers, yet I have transitioned to negative while still having the virus, which is quite distressing for me.
Thank you for taking the time to address my concerns amidst your busy schedule.
I greatly appreciate your help.

Mr. Chen, 30~39 year old female. Ask Date: 2012/04/10

Dr. Li Yongming reply Gastroenterology and Hepatology

You have raised many excellent questions, many of which are still intriguing topics in medical research.
The mechanism of action of the drug "Baraclude" (entecavir) is to inhibit the further replication of the hepatitis B virus, thereby achieving therapeutic effects.
These medications suppress the steps necessary for viral replication, causing the virus to temporarily enter a dormant state.
However, since the "covalently closed circular DNA" (cccDNA) that initiates this response remains unaffected, abruptly discontinuing the medication without reaching the treatment goal increases the risk of relapse over time.
The treatment duration for these medications typically lasts at least one year.
During the treatment process, when liver function tests, such as ALT, return to normal and the viral load in the blood begins to decrease, it indicates that the treatment is starting to take effect.
When the e antigen disappears and the e antibody appears, it signifies treatment success.
Conversely, if there are signs of elevated liver function during treatment, or if a previously stable low viral load suddenly increases by more than tenfold, and after ruling out non-compliance with medication, these are warning signs of drug resistance, which may necessitate switching to other medications to maintain therapeutic efficacy.

Hepatitis B can indeed be cured, but the proportion is very low; among 100 patients treated with oral medications, only 2 to 3 fortunate individuals ultimately achieve not only the treatment goal but also meet the definition of a cure.
A "cure" refers to the disappearance of hepatitis B surface antigen, and typically, these patients show no detectable virus in their blood and are unlikely to face the shadow of relapse in the future.
Successful treatment of hepatitis B does not necessarily equate to a "cure." The primary goal of successful hepatitis B treatment is seroconversion of the e antigen, normalization of liver function tests, and even after achieving these targets, treatment should continue for at least six months to maintain effectiveness and reduce the chance of relapse.
As for the mechanism by which the immune system clears the hepatitis virus, eliminates the cccDNA hidden within liver cells, how immunity suppresses the virus, how the virus mutates, and the related or determining factors between e antigen-negative hepatitis B and inactive carriers remain challenging questions in medical research.

Reply Date: 2012/04/10

More Info

Understanding the treatment of chronic Hepatitis B, particularly with the use of Baraclude (entecavir), involves several important considerations. Your concerns reflect a common experience among patients dealing with this condition, and I will address your questions while providing insights based on current medical knowledge.

1. Mechanism of Action and Viral Persistence: Baraclude is an antiviral medication that works by inhibiting the replication of the Hepatitis B virus (HBV) DNA. While it effectively suppresses the virus in the bloodstream, it does not eliminate the virus from the liver cells. This means that even if your blood tests show reduced liver enzymes and viral load, the virus can still persist in the liver, potentially leading to ongoing inflammation and fibrosis. Chronic inflammation can indeed contribute to liver damage over time, which is why regular monitoring of liver function and fibrosis is crucial.
2. Stopping Treatment and Risk of Recurrence: The decision to stop antiviral therapy is complex. Generally, it is recommended that patients achieve a sustained virologic response, which means having undetectable HBV DNA levels for a certain period (often at least three consecutive tests) before considering discontinuation of therapy. However, even after stopping treatment, there is a significant risk of relapse, with studies indicating that relapse rates can exceed 30% within the first year after stopping therapy. If the virus reactivates, you may need to resume antiviral therapy. The concern about drug resistance is valid; however, entecavir has a high barrier to resistance, especially when taken as prescribed.

3. Understanding e-Antigen and Mutations: Your situation as an e-antigen negative patient indicates that you may have a more complex form of the virus, often associated with mutations that allow the virus to evade the immune response. These mutations can occur due to various factors, including the immune system's inability to control the virus effectively. It is essential to discuss with your healthcare provider the specific type of mutation you may have, as this can influence treatment decisions and the choice of antiviral therapy.

4. Lifestyle and Monitoring: Maintaining a healthy lifestyle is crucial for managing chronic Hepatitis B. Regular follow-ups with your healthcare provider, including liver function tests and imaging studies, are essential to monitor the progression of liver disease and the effectiveness of treatment. If you are considering travel or changes in your routine, it is advisable to discuss these plans with your doctor to ensure that your health remains stable.

5. Future Treatment Options: If you experience a relapse after stopping Baraclude, there are other antiviral medications available, such as tenofovir, which may be effective. The choice of medication will depend on various factors, including your specific viral strain, liver function, and any potential resistance patterns.

In summary, while Baraclude is effective in managing chronic Hepatitis B, it is important to understand that it does not cure the infection. Ongoing monitoring and a comprehensive approach to treatment are essential to manage the disease effectively. If you have further questions or concerns, I encourage you to maintain open communication with your healthcare provider, who can provide personalized guidance based on your health status.

Similar Q&A

Managing Chronic Hepatitis B: Treatment Decisions and Health Concerns

Hello Dr. Lin, three years ago I had an acute phase of hepatitis B, with liver enzyme levels exceeding 2000. An ultrasound showed no tumors. After taking Baraclude for a month or two, my liver enzymes returned to normal (usually in the low 20s), and the ultrasound was also normal...

Dr. Lin Minghui reply Gastroenterology and Hepatology
Hello: 1. For patients with chronic hepatitis B who exhibit significant inflammation or high levels of viral replication, consideration should be given to pharmacological treatment. Treatment options include antiviral medications or interferon. The interferon treatment regimen ...

Enhancing Interferon Treatment for Chronic Hepatitis B with Baraclude

Hello, Doctor. I am a carrier of hepatitis B and have been regularly undergoing ultrasound and blood tests for a long time. However, since November of last year, my liver enzyme levels have been rising to over 200, and my surface antigen level is at 80,000. My attending physician...

Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello, Sir: Q1 Combination therapy is a recommendation based on professional experience, and while it is not inappropriate, there are currently no definitive human trial results to support it. Therefore, it is unclear what the best combination would be. Q2 There will be no re...

Managing Hepatitis B: How to Reduce Viral Load and Treatment Options

Hello Dr. Chen, I have been living with Hepatitis B for over ten years. My liver enzyme levels are 55 and 35, and my viral load is 100,000. An ultrasound showed a 0.6 cm white spot. Can I apply for health insurance coverage for Baraclude? Also, what is the effectiveness of Baracl...

Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello, Xiao Jiang. 1. For the application of medication for hepatitis B, it is essential to provide proof of a medical history of more than 6 months, with GPT levels greater than 80 for over 3 months. 2. Baraclude is one of the two first-line medications in the world. It has m...

Does Weight Affect the Efficacy of Baraclude in Treating Hepatitis B?

After taking Baraclude 0.5 mg for the treatment of hepatitis B for two years, with positive e-antigen and detectable viral load, does a body weight of 90 kg affect the efficacy of the medication? Should I consider self-paying to increase the dosage to 1 mg?

Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello, sir: Please observe a series of changes in viral load. If there is no increase and only a slow decrease, medication can be continued (the health insurance does not currently allow for 1mg under these circumstances). Changhua Hospital cares about your health. Chen Shidian.